James F. Oliviero III

Insider Reports History

Entity
Individual
Location
C/O Keryx Biopharmaceuticals, Inc., 750 Lexington Avenue, New York, NY
Signature
/s/ James F. Oliviero, III
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James F. Oliviero III:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Checkpoint Therapeutics, Inc. CEO, President and Director, Director COMMON STOCK 1.94M $3.98M $2.05 Jun 26, 2024 Direct
Nuvectis Pharma, Inc. Director Common Stock 57.8K $390K $6.74 Jun 13, 2024 Direct
Checkpoint Therapeutics, Inc. CEO, President and Director, Director COMMON STOCK (RESTRICTED) 2M May 24, 2024 Direct

Insider Reports Filed by James F. Oliviero III

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CKPT Checkpoint Therapeutics, Inc. Jun 26, 2024 2 -$50.5K 4 Jun 28, 2024 CEO, President and Director, Director
NVCT Nuvectis Pharma, Inc. Jun 13, 2024 1 $0 4 Jun 13, 2024 Director
CKPT Checkpoint Therapeutics, Inc. May 24, 2024 1 $0 4 May 24, 2024 CEO, President and Director, Director
CKPT Checkpoint Therapeutics, Inc. Feb 28, 2024 2 -$12.1K 4 Mar 1, 2024 CEO, President and Director, Director
CKPT Checkpoint Therapeutics, Inc. Feb 1, 2024 2 -$23.9K 4 Feb 2, 2024 CEO, President and Director, Director
CKPT Checkpoint Therapeutics, Inc. Dec 31, 2023 2 $0 5 Feb 2, 2024 CEO, President and Director, Director
NVCT Nuvectis Pharma, Inc. Jun 16, 2023 1 $0 4 Jun 20, 2023 Director
CKPT Checkpoint Therapeutics, Inc. Mar 31, 2023 1 $0 4 Apr 4, 2023 CEO, President and Director, Director
CKPT Checkpoint Therapeutics, Inc. Feb 27, 2023 3 -$53.2K 4 Mar 3, 2023 CEO, President and Director, Director
CKPT Checkpoint Therapeutics, Inc. Feb 1, 2023 1 -$48.9K 4 Feb 3, 2023 CEO, President and Director, Director
CKPT Checkpoint Therapeutics, Inc. Jan 10, 2023 1 -$25.8K 4 Jan 12, 2023 CEO, President and Director, Director
CKPT Checkpoint Therapeutics, Inc. Dec 31, 2022 1 $0 5 Jan 12, 2023 CEO, President and Director, Director
CKPT Checkpoint Therapeutics, Inc. Jun 17, 2022 4 -$301K 4 Jul 1, 2022 CEO, President and Director, Director
NVCT Nuvectis Pharma, Inc. Apr 1, 2022 1 $0 4 Apr 5, 2022 Director
NVCT Nuvectis Pharma, Inc. Feb 8, 2022 0 $0 3 Feb 8, 2022 Director
CKPT Checkpoint Therapeutics, Inc. Jan 31, 2022 1 $0 4 Feb 2, 2022 CEO, President and Director, Director
CKPT Checkpoint Therapeutics, Inc. Jan 1, 2022 8 -$1.91M 4 Apr 22, 2022 CEO, President and Director, Director